122 related articles for article (PubMed ID: 3081722)
1. Selective thromboxane synthetase inhibitors. 2. 3-(1H-imidazol-1-ylmethyl)-2-methyl-1H-indole-1-propanoic acid and analogues.
Cross PE; Dickinson RP; Parry MJ; Randall MJ
J Med Chem; 1986 Mar; 29(3):342-6. PubMed ID: 3081722
[TBL] [Abstract][Full Text] [Related]
2. Selective thromboxane synthetase inhibitors. 4. 2-(1H-imidazol-1-ylmethyl) carboxylic acids of benzo[b]furan, benzo[b]thiophene, indole, and naphthalene.
Cross PE; Dickinson RP; Parry MJ; Randall MJ
J Med Chem; 1986 Sep; 29(9):1643-50. PubMed ID: 3091830
[TBL] [Abstract][Full Text] [Related]
3. Selective thromboxane synthetase inhibitors. 1. 1-[(Aryloxy)alkyl]-1H-imidazoles.
Cross PE; Dickinson RP; Parry MJ; Randall MJ
J Med Chem; 1985 Oct; 28(10):1427-32. PubMed ID: 3930740
[TBL] [Abstract][Full Text] [Related]
4. CGS 15435A, a thromboxane synthetase inhibitor with an extended duration of action: a comparison with dazoxiben.
Olson RW; Cohen DS; Ku EC; Kimble EF; Renfroe HB; Smith EF
Eur J Pharmacol; 1987 Jan; 133(3):265-73. PubMed ID: 3104066
[TBL] [Abstract][Full Text] [Related]
5. Selective thromboxane synthetase inhibitors. 3. 1H-imidazol-1-yl-substituted benzo[b]furan-, benzo[b]thiophene-, and indole-2- and -3-carboxylic acids.
Cross PE; Dickinson RP; Parry MJ; Randall MJ
J Med Chem; 1986 Sep; 29(9):1637-43. PubMed ID: 3746813
[TBL] [Abstract][Full Text] [Related]
6. Imidazo[1,5-a]pyridines: a new class of thromboxane A2 synthetase inhibitors.
Ford NF; Browne LJ; Campbell T; Gemenden C; Goldstein R; Gude C; Wasley JW
J Med Chem; 1985 Feb; 28(2):164-70. PubMed ID: 3918169
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships in an imidazole-based series of thromboxane synthase inhibitors.
Manley PW; Allanson NM; Booth RF; Buckle PE; Kuzniar EJ; Lad N; Lai SM; Lunt DO; Tuffin DP
J Med Chem; 1987 Sep; 30(9):1588-95. PubMed ID: 3305945
[TBL] [Abstract][Full Text] [Related]
8. 3-(1-imidazolylmethyl) indoles: potent and selective inhibitors of human blood platelet thromboxane synthetase.
Cross PE; Dickinson RP; Parry MJ; Randall MJ
Agents Actions; 1981 May; 11(3):274-80. PubMed ID: 7020379
[TBL] [Abstract][Full Text] [Related]
9. Effects of 1-[3-(4-benzhydryl-1-piperazinyl)propyl]-3- (1H-imidazol-1-ylmethyl)-1H-indole-6-carboxylic acid with thromboxane A2 synthetase inhibitory and H1-blocking activities on anaphylactic bronchospasm.
Nakamura S; Shirahase H; Kanda M; Wada K; Kamiya S; Matsui H; Kurahashi K
Arzneimittelforschung; 1996 Nov; 46(11):1067-71. PubMed ID: 8955866
[TBL] [Abstract][Full Text] [Related]
10. Agents combining thromboxane receptor antagonism with thromboxane synthase inhibition: [[[2-(1H-imidazol-1-yl)ethylidene]amino]oxy]alkanoic acids.
Cozzi P; Giordani A; Menichincheri M; Pillan A; Pinciroli V; Rossi A; Tonani R; Volpi D; Tamburin M; Ferrario R
J Med Chem; 1994 Oct; 37(21):3588-604. PubMed ID: 7932586
[TBL] [Abstract][Full Text] [Related]
11. Thromboxane A2 synthetase inhibitors with histamine H1-blocking activity: synthesis and evaluation of a new series of indole derivatives.
Kamiya S; Matsui H; Shirahase H; Nakamura S; Wada K; Kanda M; Shimaji H; Kakeya N
Chem Pharm Bull (Tokyo); 1995 Oct; 43(10):1692-5. PubMed ID: 8536342
[TBL] [Abstract][Full Text] [Related]
12. Thromboxane synthase inhibitors. Synthesis and pharmacological activity of (R)-, (S)-, and (+/-)-2,2-dimethyl-6-[2-(1H-imidazol-1-yl)-1-[[(4-methoxyphenyl)- methoxy]methyl]ethoxy]hexanoic acids.
Manley PW; Tuffin DP; Allanson NM; Buckle PE; Lad N; Lai SM; Lunt DO; Porter RA; Wade PJ
J Med Chem; 1987 Oct; 30(10):1812-8. PubMed ID: 3656356
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological studies on the TXA2 synthetase inhibitor (E)-3-[p-(1H-imidazol-1-ylmethyl)phenyl]-2-propenoic acid (OKY-046).
Hiraku S; Taniguchi K; Wakitani K; Omawari N; Kira H; Miyamoto T; Okegawa T; Kawasaki A; Ujiie A
Jpn J Pharmacol; 1986 Jul; 41(3):393-401. PubMed ID: 3093741
[TBL] [Abstract][Full Text] [Related]
14. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
[TBL] [Abstract][Full Text] [Related]
15. Taurine and icosanoids in the heart.
Chanh PH; Chahine R; Pham HC; Dossou-Gbete V; Navarro-Delmasure C
Prostaglandins Leukot Med; 1987 Aug; 28(3):243-54. PubMed ID: 3310012
[TBL] [Abstract][Full Text] [Related]
16. Effects of flunixin meglumine, phenylbutazone and a selective thromboxane synthetase inhibitor (UK-38,485) on thromboxane and prostacyclin production in healthy horses.
Hardee MM; Moore JN; Hardee GE
Res Vet Sci; 1986 Mar; 40(2):152-6. PubMed ID: 3517992
[TBL] [Abstract][Full Text] [Related]
17. Thromboxane modulating agents. 3. 1H-imidazol-1-ylalkyl- and 3-pyridinylalkyl-substituted 3-[2-[(arylsulfonyl)amino]ethyl]benzenepropanoic acid derivatives as dual thromboxane synthase inhibitor/thromboxane receptor antagonists.
Dickinson RP; Dack KN; Long CJ; Steele J
J Med Chem; 1997 Oct; 40(21):3442-52. PubMed ID: 9341919
[TBL] [Abstract][Full Text] [Related]
18. Thromboxane synthetase inhibitors and antihypertensive agents. 3. N-[(1H-imidazol-1-yl)alkyl]heteroaryl amides as potent enzyme inhibitors.
Press JB; Wright WB; Chan PS; Haug MF; Marsico JW; Tomcufcik AS
J Med Chem; 1987 Jun; 30(6):1036-40. PubMed ID: 3585902
[TBL] [Abstract][Full Text] [Related]
19. [Synthesis and platelet aggregation inhibitory activity of analogues of 4-([2-(1H-imidazol-1-yl)-1-(4-substituted-phenyl)ethoxy]methyl)benzoic acids].
Wu QY; Yang JQ
Yao Xue Xue Bao; 1991; 26(10):741-6. PubMed ID: 1823715
[TBL] [Abstract][Full Text] [Related]
20. [(1H-imidazol-1-yl)methyl]- and [(3-pyridinyl)methyl]pyrroles as thromboxane synthetase inhibitors.
Martinez GR; Walker KA; Hirschfeld DR; Maloney PJ; Yang DS; Rosenkranz RP
J Med Chem; 1989 Apr; 32(4):890-7. PubMed ID: 2704033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
